🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

719 results for “LI” Clear

  1. influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)

    PANDEMRIX

    J07BB02

  2. influenza vaccine (live attenuated, nasal)

    FLUENZ TETRA

    J07BB03

  3. influenza vaccine (split virion, inactivated)

    INTANZA

    J07BB02

  4. insulin

  5. insulin aspart

    FIASP PENFILL NovoThirteen

    SUBCUTANEOUS approved

    A10AB05

  6. insulin aspart + insulin aspart protamine

    NOVOMIX 30 FLEXPEN NovoThirteen

  7. insulin aspart protamine recombinant

    NOVOLOG MIX 50/50

    SUBCUTANEOUS approved

  8. insulin aspart recombinant

    NOVOLOG PENFILL

    SUBCUTANEOUS approved

  9. insulin aspart-szjj

    MERILOG

    SOLUTION approved

  10. insulin aspart-xjhz

    KIRSTY

    SOLUTION approved

  11. insulin degludec

    RYZODEG

    SUBCUTANEOUS approved

    A10AE06

  12. insulin degludec + insulin aspart

    RYZODEG PENFILL NovoThirteen

  13. insulin degludec / insulin aspart

    RYZODEG

  14. insulin detemir

    LEVEMIR FLEXPEN NovoThirteen

    INJECTION approved

    A10AE05

  15. insulin detemir recombinant

    LEVEMIR FLEXTOUCH

    SUBCUTANEOUS approved

  16. insulin glargine

    OPTISULIN Sanofi-aventis Healthcare Pty Ltd

    INJECTION approved

    A10AE04

  17. insulin glargine [insulin glargine biosimilar 1]

    INSULIN GLARGINE BS [LILLY]

  18. insulin glargine recombinant

    TOUJEO SOLOSTAR

    INJECTION approved

  19. insulin glargine-aglr

    REZVOGLAR

    INJECTION approved

  20. insulin glargine-aldy

    LANGLARA Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    SUBCUTANEOUS approved

  21. insulin glargine-yfgn

    SEMGLEE

    INJECTION approved

  22. insulin glulisine

    APIDRA Sanofi-aventis Healthcare Pty Ltd

    A10AB06

  23. insulin glulisine recombinant

    APIDRA SOLOSTAR

    SUBCUTANEOUS approved

  24. insulin human

    COMBIMARV

    SUBCUTANEOUS approved

    A10AB01;A10AC01

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources